1. Home
  2. SAMG vs ADVB Comparison

SAMG vs ADVB Comparison

Compare SAMG & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$14.40

Market Cap

125.5M

Sector

Finance

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

HOLD

Current Price

$5.47

Market Cap

109.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
ADVB
Founded
2002
2014
Country
United States
United States
Employees
N/A
31
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.5M
109.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
SAMG
ADVB
Price
$14.40
$5.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.2K
200.2K
Earning Date
06-19-2026
01-01-0001
Dividend Yield
5.94%
N/A
EPS Growth
N/A
N/A
EPS
0.56
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.62
N/A
P/E Ratio
$25.71
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$13.23
$0.19
52 Week High
$16.97
$5.82

Technical Indicators

Market Signals
Indicator
SAMG
ADVB
Relative Strength Index (RSI) 33.07 83.52
Support Level $13.41 $0.36
Resistance Level $15.50 $5.75
Average True Range (ATR) 0.46 0.53
MACD -0.13 0.06
Stochastic Oscillator 15.16 76.73

Price Performance

Historical Comparison
SAMG
ADVB

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: